Extract from the Register of European Patents

EP Citations: EP3584241

Cited inSearch
Type:Patent literature
Publication No.:WO0102369  [XA]
 (AGOURON PHARMA [US]) [X] 13 * Family member of JP-2003-503481 cited in the International Search Report * [A] 1-12,14,15;
Type:Patent literature
Publication No.:WO2004094388  [XA]
 (SIGNAL PHARM LLC [US], et al) [X] 13 * Family member of JP-A-2006-523721 cited in the International Search Report * [A] 1-12,14,15;
Type:Patent literature
Publication No.:EP1510516  [XA]
 (EISAI CO LTD [JP]) [X] 13 * Family member of WO-A-03/101968 cited in the International Search Report * [A] 1-12,14,15;
Type:Patent literature
Publication No.:EP1650194  [XA]
 (KYOWA HAKKO KOGYO KK [JP]) [X] 13 * Family member of WO-A-2005/012258 cited in the International Search Report * [A] 1-12,14,15;
Type:Patent literature
Publication No.:WO2009144554  [AD]
 (PFIZER [US], et al) [AD] 1-15 * Family member of JP-A-2011-521939 cited in the International Search Report *;
Type:Patent literature
Publication No.:EP3333157  [E]
 (HARBIN ZHENBAO PHARMACEUTICAL CO LTD [CN], et al) [E] 1-15* Family member of WO-A-2017/024968 cited in the International Search Report *
Cited inInternational search
Type:Patent literature
Publication No.:JP2003503481  [XA]
 [X] 13 * , * [A] 1-12, 14-16;
Type:Patent literature
Publication No.:WO03101968  [XA]
 (EISAI CO LTD [JP], et al) [X] 13, 15 * , * [A] 1-12, 14, 16;
Type:Patent literature
Publication No.:WO2005012258  [XA]
 (KYOWA HAKKO KOGYO KK [JP], et al) [X] 13 * , 1 15, 12 1 & US 2006/0281789 Al, claims, Table 1, compound 15, EXAMPLE 12, Step 1 & EP 1650194 A1 & CA 2518951 A1 * [A] 1-12, 14-16;
Type:Patent literature
Publication No.:WO2005094823  [XA]
 (KYOWA HAKKO KOGYO KK [JP], et al) [X] 13 [A] 1-12, 14-16;
Type:Patent literature
Publication No.:JP2006523721  [XA]
 [X] 13 * , * [A] 1-12, 14-16;
Type:Patent literature
Publication No.:JP2011521939  [A]
 [A] 1-16 * , [0203]-[0206] & US 2011/0028390 A1, paragraphs [0214]-[0217] & WO 2009144554 A1 & EP 2297163 A1 & CA 2724774 A1 *;
Type:Patent literature
Publication No.:WO2016129933  [XA]
 (DAE WOONG PHARMA [KR]) [X] 13-16 * , Claims, 31 Reaction Scheme 2, Examples 62, 134 & EP 3256449 A2 & KR 10-2016-0098909 A & CN 107108517 A * [A] 1-12;
Type:Patent literature
Publication No.:WO2017024968  [PXA]
 (MEDSHINE DISCOVERY INC [CN]) [PX] 15 * , 49 & TW 201613928 A *[PA] 1-14, 16;
Type:Non-patent literature
Publication information:[XA]  - LAUFER, RADOSLAW et al., "The Discovery of PLK4 Inhibitors: (E)-3-((lH-Indazol-6-yl)methylene)indolin-2-ones as Novel Antiproliferative Agents", Journal of Medicinal Chemistry, (20130000), vol. 56, no. 15, ISSN 0022-2623, pages 6069 - 6087, XP055535331 [X] 13 * , Scheme 2 36, Table 3 51 * [A] 1-12, 14-16
DOI: http://dx.doi.org/10.1021/jm400380m
Type:Non-patent literature
Publication information:[XA]  - SAMPSON, PETER B. et al., "The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro [cyclopropane-1, 3' [3H] indol] -2' (1'H)-ones as Orally Bioavailable Antitumor Agents", Journal of Medicinal Chemistry, (20150000), vol. 58, no. 1, ISSN 0022-2623, pages 130 - 146, XP055535332 [X] 13 * , Scheme3 (v), 142 14-16 * [A] 1-12, 14-16
DOI: http://dx.doi.org/10.1021/jm500537u
Type:Non-patent literature
Publication information:[A]  - NORRIS, TIMOTHY et al., "Heavy-Metal-Free Reduction Methodology for Large-Scale Synthesis Applicable to Heterocyclic and Arylhydrazines", Organic Process Research & Development, (20090000), vol. 13, no. 2, ISSN 1083-6160, pages 354 - 357, XP055535334 [A] 1-16 * , Scheme 1 *
DOI: http://dx.doi.org/10.1021/op8002163
Cited inby applicant
Type:Patent literature
Publication No.:JP2004514706  
Type:Patent literature
Publication No.:WO2009144554  
Type:Patent literature
Publication No.:JP2016530210  
Type:Non-patent literature
Publication information:   - Org. Process Res. & Dev., (20140000), pages 266 - 274
Type:Non-patent literature
Publication information:   - Org. Process Res. & Dev., (20090000), pages 354 - 357
Type:Non-patent literature
Publication information:   - Greene's Protective Groups in Organic Synthesis